Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.
about
Multikinase Inhibitor-Induced Hand-Foot Skin Reaction: A Review of Clinical Presentation, Pathogenesis, and Management.Response to regorafenib at an initial dose of 120 mg as salvage therapy for metastatic colorectal cancerPhase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment.Regorafenib in the treatment of colorectal cancer.Novel anti-angiogenic therapeutic strategies in colorectal cancer.An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients.Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution.Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients.Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma.Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment.Research progress on common adverse events caused by targeted therapy for colorectal cancer.Adverse events risk associated with regorafenib in the treatment of advanced solid tumors: meta-analysis of randomized controlled trials
P2860
Q30250106-7F0B6629-AAA2-45A6-AEC7-BEF55F51BE29Q33441453-07655467-3AF3-4C69-AC07-F5F740D68F9BQ37544401-C8C93541-E7AE-44CC-AC9A-52084DAD8BC3Q38630817-8B4BC8E9-6003-44BA-AAB6-9FED11D1314AQ38759141-AC58493D-7929-4AE7-BE43-3A3C71FE2800Q38869809-E5AF2584-A49D-41FE-9464-BFC46E99AB5BQ39198469-196D8E40-6559-4312-8A0D-85E7D60B1D3AQ41534349-232D5796-D0B0-45B7-8819-0A43C428B610Q45329617-E85F4B97-97DA-4A34-BB91-DE4CBE763327Q50969620-4370AC1F-3633-4D89-ADA5-2350A2CD9C00Q55080669-413E04F8-12B6-4900-AC02-87262F707DB6Q55360813-8CB0C90B-7BCC-4B4C-AF67-D10316D1D25BQ57485195-6C8E6C62-BDCE-4520-B9E7-8682805FB811
P2860
Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Regorafenib-associated hand-fo ...... s, prevention, and management.
@ast
Regorafenib-associated hand-fo ...... s, prevention, and management.
@en
type
label
Regorafenib-associated hand-fo ...... s, prevention, and management.
@ast
Regorafenib-associated hand-fo ...... s, prevention, and management.
@en
prefLabel
Regorafenib-associated hand-fo ...... s, prevention, and management.
@ast
Regorafenib-associated hand-fo ...... s, prevention, and management.
@en
P2093
P2860
P921
P356
P1433
P1476
Regorafenib-associated hand-fo ...... is, prevention, and management
@en
P2093
B McLellan
E Van Cutsem
P2860
P304
P356
10.1093/ANNONC/MDV244
P5008
P577
2015-06-01T00:00:00Z